# Mary J. Fidler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-j-fidler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,016 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 27 |
| i10-index | 60 |
| Last Known Institution | Rush University Medical Center |
| OpenAlex ID | https://openalex.org/A5040798556 |
| ORCID iD | 0009-0004-9180-8626 |
| Works | 228 |

## Researcher papers

- [Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial](https://scholariq.org/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/)
- [Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-versus-methotrexate-docetaxel-or-cetuximab-for-recurrent-or/)
- [Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer](https://scholariq.org/papers/prognostic-value-of-xanthine-oxidoreductase-expression-in-patients-with-non/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

## Researcher university

- [Rush University Medical Center](https://scholariq.org/institutions/rush-university-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.